[29P-pm] Clinical Pharmacy

[29P-pm440S] Biomarker for atezolizumab/ bevacizumab combination therapy with soluble MICA in patients with HCC

○Ayano Yamada¹, Yuka Kyoso¹, Kunihide Mori^1,2, Yasuaki Tatsumi¹, Takanori Wakui², Hidenari Nagai², Koji Higai¹ (1. Faculty of Pharm. Sci. , Toho Univ. , 2. Div. of Gastroentero. and Hepatol. , Dep. of Int. Med. (Omori), Sch. of Med. , Faculty of Med. , Toho Univ.)